• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSISST) BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSISST) BYPASS Back to Search Results
Model Number 106524INT
Device Problems Mechanical Problem (1384); Infusion or Flow Problem (2964)
Patient Problems Septic Shock (2068); Cardiogenic Shock (2262); Thrombosis/Thrombus (4440); Heart Failure/Congestive Heart Failure (4446)
Event Date 08/20/2021
Event Type  Injury  
Manufacturer Narrative
No further information was provided.A supplemental report will be submitted once the manufacturer¿s investigation is completed.
 
Event Description
It was reported that the patient had a computed tomography (ct) scan that revealed a thrombus on the outflow graft.On (b)(6) 2021 a surgical procedure to correct the thrombus was performed.The driveline was cut by accident during the surgery.The patient was stable during surgery so the surgical team decided to explant the pump and observe how the patient recovers.Following the driveline cut the patient started to have cardiogenic shock and right ventricular failure.The clinical team decided to implant a biventricular centrimag.
 
Event Description
The patient had been experiencing incessant low flow alarms prior to the ct scan that had revealed thrombus in the outflow graft.After the driveline had been cut during surgery, the patient was stable with an ejection fraction of 33%, premature ventricular contraction of 14.While waiting for a heart transplant, the patient was unable to recover and subsequently passed away.Related manufacturer's reference number: 3003306248-2021-05720.
 
Manufacturer Narrative
Manufacturer's investigation conclusion: the relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.Heartmate 3 left ventricle assist system (lvas) instructions for use (ifu) is currently available.Section 1, ¿introduction¿, lists device thrombosis as a potential adverse event that may be associated with the use of the heartmate 3 lvas.Section 4, ¿system monitor,¿ explains that the low flow hazard alarm occurs when pump flow is less than 2.5 liters per minute (lpm).A 10-second delay is imposed between the detection of the low flow status and the activation of the associated audio and visual indicators on the system controller.Changes in patient conditions can result in low flow.Section 6, ¿patient care and management,¿ outlines the suggested anticoagulation regimen and international normalized ratio (inr) range that should be maintained for patients using the heartmate 3 lvas as well as the suggested anticoagulation modifications.Section 7 entitled ¿alarms and troubleshooting¿ explains all system alarms and the recommended actions associated with them.Heartmate 3 lvas patient handbook section 5 entitled "alarms and troubleshooting" outlines all system controller alarms as well as how to respond to each alarm condition.The reported suspected thrombus in the outflow graft could not be confirmed through this evaluation.Additionally, review of the submitted log files confirmed low flow alarms; however, the cause of these low flow events could not be conclusively determined.(b)(6) was returned assembled with the pump cable severed approximately 2¿ from the pump housing.The distal portion and the modular cable were not returned.The sealed outflow graft was returned attached to the pump cover outlet port with the outflow graft bend relief secured to the outflow graft attachment.The distal end of the outflow graft was closed with sutures and sewn to the bend relief.The apical cuff was not returned.Examination of the interior of the outflow graft did not reveal any developed depositions or thrombus formations.Upon disassembly of the pump body, examination of the remaining blood-contacting surfaces revealed no depositions or thrombus formations.Visual inspection of the pump rotor and rotor well did not reveal any obvious surface scratches or defects.The submitted and retrieved log files captured low flow alarms starting on 18aug2021.No other atypical events were captured and the device functioning as intended.(b)(6) was cleaned, rebuilt, and functionally tested on a mock circulatory loop.The device operated as intended and in accordance with manufacturing specifications.No further information was provided.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE 3 LVAS IMPLANT KIT
Type of Device
VENTRICULAR (ASSISST) BYPASS
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer (Section G)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer Contact
bob fryc
6035 stoneridge drive
pleasanton, CA 94588
7818528204
MDR Report Key12536717
MDR Text Key273540999
Report Number2916596-2021-05025
Device Sequence Number1
Product Code DSQ
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
P160054
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/31/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/14/2021
Device Model Number106524INT
Device Lot Number6661793
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/18/2021
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 08/28/2021
Initial Date FDA Received09/27/2021
Supplement Dates Manufacturer Received01/17/2022
Supplement Dates FDA Received02/01/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/25/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Hospitalization; Required Intervention;
Patient Age72 YR
Patient SexMale
Patient Weight95 KG
-
-